Higuchi et al.
and 2-chloromethyl-4-nitropyridine (1:1) in a manner analogous
to that used to prepare (4-MeO)2TPA; it was isolated as light yellow
oil in a 41% yield. H NMR (400 MHz, CDCl3): δ 3.94 (6H, s),
4.06 (2H, s), 7.16 (2H, dd, J ) 7.3 Hz, J′ ) 4.9 Hz), 7.54 (2H, d,
J ) 7.3 Hz), 7.68 (2H, dd, J ) 7.3 Hz, J′ ) 7.3 Hz), 7.84 (1H, dd,
J ) 5.4 Hz, J′ ) 2.4 Hz), 8.35 (1H, d, J ) 2.4 Hz), 8.55 (2H, d,
J ) 4.9 Hz,), 8.79 (1H, d, J ) 5.4 Hz). 13C NMR (100 MHz,
CDCl3): δ 59.7, 60.5, 114.3, 115.3, 122.1, 123.0, 136.5, 149.1,
151.0, 154.3, 158.5, 163.7.
the catecholate ligand but also shifts the spin equilibrium to
a low-spin state. The logarithm of the reaction rate constant
with O2 is linearly correlated with the energy gap between
catecholatoiron(III) and semiquinonatoiron(II) states for the
high-spin complexes 1-3, although 5, which contains 36%
of low-spin species at 243 K, deviates negatively from
linearity. In this report, we elucidated the spin delocalization
on the catecholate ligand of high-spin and low-spin catecho-
latoiron(III) species by means of 1H NMR, EPR, and UV-
vis-NIR spectroscopies to clarify the correlation of spin
states and spin delocalization with the O2 reactivity of
catecholatoiron(III) complexes.
1
Bis(4-nitroypyridin-2-ylmethyl)(pyridin-2-ylmethyl)amine, (4-
NO2)2TPA. (4-NO2)2TPA was prepared using 4-chloro-2-nitro-
methylpyridine in a manner analogous to that used to preprare (4-
1
MeO)2TPA; it was isolated as light yellow oil in a 66% yield. H
NMR (400 MHz, CDCl3): δ 3.98 (2H, s), 4.12 (4H, s), 7.12 (1H,
ddd, J ) 7.3 Hz, J′ ) 4.9 Hz, J′′ ) 1.0 Hz), 7.49 (1H, dd, J ) 7.3
Hz, J′ ) 1.0 Hz), 7.69 (1H, ddd, J ) 7.3 Hz, J′ ) 7.3 Hz, J′′ )
1.0 Hz), 7.88 (2H, dd, J ) 5.4 Hz, J′ ) 2.0 Hz), 8.31 (2H, d, J )
2.0 Hz), 8.57 (1H, dd, J ) 4.9 Hz, J′ ) 1.0 Hz), 8.84 (2H, d, J )
5.4 Hz). 13C NMR (100 MHz, CDCl3): δ 59.9, 60.6, 114.6, 115.5,
122.4, 123.1, 136.6, 149.3, 151.3, 154.3, 157.9, 162.8.
General Procedure for the Synthesis of Catecholatoiron(III)
Complexes. Substituted TPA (0.30 mmol) in methanol (2 mL) and
4Cl-catH2 (0.043 g, 0.30 mmol) in methanol (2 mL) under N2 were
added to a stirred solution of FeCl3 (0.049 g, 0.30 mmol) in
methanol (2 mL). After the addition of Et3N (83.6 µL, 0.60 mmol),
the reaction mixture was stirred for 10 min. NaBPh4 (0.10 g, 0.30
mmol) was added to the resulting dark purple blue solution, and
the mixture was stirred for 2 h, causing the immediate precipitation
of a powder, which was washed with methanol several times and
dried in vacuo.
[FeIII((4-MeO)2TPA)(4Cl-cat)]BPh4 (1). Complex 1 was iso-
lated as a gray powder in an 83% yield. ESI-MS: m/z 548.1
([FeIII((4-MeO)2TPA)(4Cl-cat)]+). Anal. Calcd for C50H45BCl-
FeN4O4: C, 69.18; H, 5.23; N, 6.45; Cl, 4.08. Found: C, 68.93;
H, 5.20; N. 6.45; Cl, 4.07. UV-vis-NIR (CH3CN, λmax, nm (ꢀ,
M-1cm-1)): 474 (2006), 764 (3038).
[FeIII(TPA)(4Cl-cat)]BPh4 (2). Complex 2 was isolated as a dark
blue powder in a 98% yield. ESI-MS: m/z 488.1 ([FeIII(TPA)(4Cl-
cat)]+). Anal. Calcd for C48H41BClFeN4O4: C, 71.35; H, 5.11; N,
6.93; Cl, 4.39. Found: C, 71.21; H, 4.94; N. 6.92; Cl, 4.15. UV-
vis-NIR (CH3CN, λmax, nm (ꢀ, M-1cm-1)): 483 (1930), 787
(2974).
Experimental Section
Materials and Preparation of Ligands and Complexes.
Reagents and solvents used were commercially available unless
otherwise stated. 4Cl-catH2 was purified by sublimation in vacuo.
The TPA ligand, 2-chloromethyl-4-methoxypyridine, 4-chloro-2-
chloromethylpyridine, and 2-chloromethyl-4-nitropyridine were
prepared using the method reported previously.54,55
Synthesis of TPA Derivatives. Bis(4-methoxypyridin-2-yl-
methyl)(pyridin-2-ylmethyl)amine, (4-MeO)2TPA. 2-Chloro-
methyl-4-methoxypyridine (0.58 g, 3.7 mmol) and 10 N NaOH (aq)
(0.8 mL, 8.0 mmol) were added to a stirred solution of 2-picolyl-
amine (0.19 g, 1.8 mmol) in water (1 mL). The reaction mixture
was stirred at room temperature for 3 days. The organic layer was
separated, and the aqueous layer was extracted with CH2Cl2 several
times. The combined organic layers were dried over Na2SO4, and
the volatile components were removed. Purification of the crude
product on an alumina column (3:1 AcOEt/CH2Cl2) gave 0.39 g
(60%) of yellow oil. 1H NMR (400 MHz, CDCl3): δ 3.85 (6H, s),
3.86 (4H, s), 3.90 (2H, s), 6.67 (2H, dd, J ) 5.9 Hz, J′ ) 2.4 Hz),
7.14 (1H, dd, J ) 7.8 Hz, J′ ) 4.9 Hz), 7.20 (2H, d, J ) 2.4 Hz),
7.56 (1H, d, J ) 7.8 Hz), 7.64 (1H, ddd, J ) 7.8 Hz, J′ ) 7.8 Hz
J′′ ) 2.0 Hz), 8.34 (2H, d, J ) 5.9 Hz), 8.53 (1H, dd, J ) 4.9 Hz,
J′ ) 2.0 Hz). 13C NMR (100 MHz, CDCl3): δ 55.1, 60.2, 60.3,
108.3, 108.6, 121.9, 122.9, 136.3, 149.0, 150.2, 159.2, 161.1, 166.1.
Bis(4-chloropyridin-2-ylmethyl)(2-pyridylmethyl)amine, (4-
Cl)2TPA. (4-Cl)2TPA was prepared using 4-chloro-2-chlorometh-
ylpyridine in a manner analogous to that used to prepare (4-
1
MeO)2TPA; it was isolated as light yellow oil in a 66% yield. H
[FeIII((4-Cl)2TPA)(4Cl-cat)]BPh4 (3). Complex 3 was isolated
as a dark blue powder in a 75% yield. ESI-MS: m/z 556.2 ([FeIII((4-
Cl)2TPA)(4Cl-cat)]+). Anal. Calcd for C50H45BClFeN4O4: C, 65.75;
H, 4.48; N, 6.39; Cl, 12.13. Found: C, 65.51; H, 4.31; N. 6.41; Cl,
11.87. UV-vis-NIR (CH3CN, λmax, nm (ꢀ, M-1cm-1)): 496
(1916), 805 (2953).
NMR (400 MHz, CDCl3): δ 3.89 (4H, s), 3.91 (2H, s), 7.18-7.15
(3H), 7.51 (1H, d, J ) 7.8 Hz), 7.56 (2H, d, J ) 2.0 Hz), 7.68
(1H, ddd, J ) 7.8 Hz, J′ ) 7.8 Hz, J′′ ) 2.0 Hz), 8.43 (2H, d, J
) 5.4 Hz), 8.56 (1H, d, J ) 4.4 Hz). 13C NMR (100 MHz,
CDCl3): δ 59.9, 60.4, 122.2, 122.5, 123.0, 123.2, 136.5, 144.5,
149.1, 149.6, 158.5, 160.9.
[FeIII((4-NO2)TPA)(4Cl-cat)]BPh4 (4). Complex 4 was isolated
as a purple powder in a 63% yield. ESI-MS: m/z 533.3 ([FeIII((4-
NO2)TPA)(4Cl-cat)]+). Anal. Calcd for C48H42BClFeN5O5 (4‚
H2O): C, 65.85; H, 4.86; N, 8.04; Cl, 4.07. Found: C, 65.84; H,
Bis(pyridin-2-ylmethyl)(4-nitroypyridin-2-ylmethyl)amine, (4-
NO2)TPA. (4-NO2)TPA was prepared using 2,2′-dipicolylamine
(52) Abbreviations used in this paper are DTBC, 3,5-di-tert-butylcatecho-
late; 4Cl-cat, 4-chlorocatecholate; cat, pyrocatecholate; Cat, catecho-
late; SQ, semiquinonate; LMCT, ligand-to-metal charge transfer; (4-
MeO)2TPA, bis(4-methoxypyridin-2-ylmethyl)(pyridin-2-ylmethyl)amine;
TPA, tris(pyridin-2-ylmethyl)amine; (4-Cl)2TPA, bis(4-chloropyridin-
2-ylmethyl)(pyridin-2-ylmethyl)amine; (4-NO2)TPA, (4-nitropyridin-
2-ylmethyl)bis(pyridin-2-ylmethyl)amine; (4-NO2)2TPA, bis(4-nitro-
pyridin-2-ylmethyl)(pyridin-2-ylmethyl)amine; BLPA, bis((6-methyl-
2-pyridyl)methyl)(2-pyridylmethyl)amine; BBA, bis(benzimidazolyl-
2-methyl)amine.
4.78; N. 8.11; Cl, 4.28. UV-vis-NIR (CH3CN, λmax, nm (ꢀ, M-1
-
cm-1)): 498 (2038), 815 (2666).
[FeIII((4-NO2)2TPA)(4Cl-cat)]BPh4 (5). Complex 5 was isolated
as a purple-blue powder in a 77% yield. ESI-MS: m/z 577.9
([FeIII((4-NO2)2TPA)(4Cl-cat)]+). Anal. Calcd for C49H43BClFeN6O7
(5‚MeOH): C, 63.28; H, 4.66; N, 9.04; Cl, 3.81. Found: C, 63.29;
H, 4.55; N. 9.31; Cl, 3.77. UV-vis-NIR (CH3CN, λmax, nm (ꢀ,
M-1cm-1)): 509 (2408), 856 (1821).
(53) Hitomi, Y.; Higuchi, M.; Minami, H.; Tanaka, T.; Funabiki, T. Chem.
Commun. 2005, 1758-1760.
Crystallographic Data Collection and Refinement of the
Structure. All measurements were performed on a Rigaku Mercury
charge-coupled device with graphite-monochromated Mo KR (λ
(54) Tamura, M.; Urano, Y.; Kikuchi, K.; Higuchi, T.; Hirobe, M.; Nagano,
T. Chem. Pharm. Bull. 2000, 48, 1514-1518.
(55) Gafford, B. G.; Holwerda, R. A. Inorg. Chem. 1989, 28, 60-66.
8812 Inorganic Chemistry, Vol. 44, No. 24, 2005